Merck completes expansion of Madrid Gonal-f API plant
Merck has completed the expansion of its biologics API manufacturing facility in Madrid, Spain increasing production capacity by 50%.
Archives for October 18, 2016
China's Tot Biopharm starts work on second plant with eye on ADC market
Tot Biopharm has started work on a second monoclonal antibody (mAb) drug production plant at China’s Suzhou Industrial Park.
Samsung Bioepis contracts Catalent to help commercialize Benepali
Samsung Bioepis has contracted Catalent to provide fill finish services for its Enbrel (etanercept) biosimilar, Benepali.